A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Novel manganese-based macrocyclic Magnetic Resonance Imaging (MRI) agent could offer an alternative to gadolinium-based agents Manganese is a trace element naturally occurring in, and efficiently ...
The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...
CORVALLIS, Ore. (KTVZ) -– Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents ...
Japan MHLW approves Bayer’s low-dose MRI contrast agent, Ambelvist: Berlin Wednesday, March 25, 2026, 11:00 Hrs [IST] Bayer announced the world’s first approval of the MRI con ...
WASHINGTON, Sept 28 (Reuters) - Certain contrast agents used in magnetic resonance imaging -- gadolinium-based products made by Bayer AG , GE and others -- will now carry the U.S. Food and Drug ...
Medical imaging often facilitates the successful diagnosis and management of cancerous growths. In particular, magnetic resonance imaging (MRI) is extensively used, especially with contrast agents, ...
A review of cases using MRI with and without contrast agent found perfect or near-perfect agreement in most cases when evaluating patients with short stature for growth hormone deficiency. Gadolinium ...
Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...